The key pathways to come out of this analysis were those of IGF-1 and TGF-β signalling modulation, particularly through expression of LTBP4, HTRA4, CILP, IGFBP5, and IGFBP6. Extensive literature exists surrounding the role of both signalling pathways in RA. Here, HTRA4 is linked to rheumatoid arthritis.